Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
age increased » rate increased (Expand Search), use increased (Expand Search), cases increased (Expand Search)
Showing 181 - 200 results of 29,129 for search '(( significant ((largest decrease) OR (age increased)) ) OR ( significant decrease decrease ))', query time: 0.58s Refine Results
  1. 181
    HPD 1466 decreases empty capsid accumulation in cells replicating HBV.

    HPD 1466 decreases empty capsid accumulation in cells replicating HBV. by Daniel P. Bradley (10306893)

    Published 2025
    Save to List
    Saved in:
  2. 182
    RTL8 incorporates into PEG10 VLPs and decreases the efficiency of release.

    RTL8 incorporates into PEG10 VLPs and decreases the efficiency of release. by Will Campodonico (20485651)

    Published 2024
    Save to List
    Saved in:
  3. 183
    CBCHCV rawdata. This file contains the raw dataset used in the analysis of decreased levels of inflammatory markers in patients with hepatitis C virus (HCV) infection. The dataset includes variables such as demographic characteristics, clinical indicators, and measured inflammatory markers.

    CBCHCV rawdata. This file contains the raw dataset used in the analysis of decreased levels of inflammatory markers in patients with hepatitis C virus (HCV) infection. The dataset... by Lu Han (151620)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 184
    Characteristics of patients who decreased their screen time by more than 60 minutes after the challenge.

    Characteristics of patients who decreased their screen time by more than 60 minutes after the challenge. by Annaëlle Le Steunf (19838110)

    Published 2024
    Save to List
    Saved in:
  5. 185
    Decreasing oxygen saturation with corresponding levels of NLR and D-dimer for understanding the interplay of inflammation.

    Decreasing oxygen saturation with corresponding levels of NLR and D-dimer for understanding the interplay of inflammation. by Narendran Gopalan (110148)

    Published 2025
    Save to List
    Saved in:
  6. 186
    Shares of antibiotic substances on total prescription by quarter from 2013 to 2019 for female and male patients with UTI (N39.0, N30.0)(female: n = 1.681.255 prescriptions; male: n = 269.151prescriptions).

    Shares of antibiotic substances on total prescription by quarter from 2013 to 2019 for female and male patients with UTI (N39.0, N30.0)(female: n = 1.681.255 prescriptions; male: n... by Thomas Hanslmeier (19949694)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  7. 187
    Shares of specialist groups prescribing 1<sup>st</sup>, 2<sup>nd</sup>, and 3<sup>rd</sup> antibiotic prescriptions in UTI treatment of females (N39.0, N30.0) in 2018 and 2019.

    Shares of specialist groups prescribing 1<sup>st</sup>, 2<sup>nd</sup>, and 3<sup>rd</sup> antibiotic prescriptions in UTI treatment of females (N39.0, N30.0) in 2018 and 2019. by Thomas Hanslmeier (19949694)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  8. 188
    Number of antibiotic prescriptions in female and male patients with UTI (N30.0 and/or N39.0).

    Number of antibiotic prescriptions in female and male patients with UTI (N30.0 and/or N39.0). by Thomas Hanslmeier (19949694)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 189
    Shares of antibiotic substances on total prescription in female patients with UTI (N39.0, N30.0) by physician specialties (GPs: n = 1.299.641 prescriptions; gynecologists n = 141.814 prescriptions; urologists n = 182.100 prescriptions).

    Shares of antibiotic substances on total prescription in female patients with UTI (N39.0, N30.0) by physician specialties (GPs: n = 1.299.641 prescriptions; gynecologists n = 141.8... by Thomas Hanslmeier (19949694)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  10. 190
    Comparison of 1<sup>st</sup>, 2<sup>nd</sup>, and 3<sup>rd</sup> antibiotic prescription.

    Comparison of 1<sup>st</sup>, 2<sup>nd</sup>, and 3<sup>rd</sup> antibiotic prescription. by Thomas Hanslmeier (19949694)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 191
    UTI diagnoses by sex and physician specialty (2013–2019).

    UTI diagnoses by sex and physician specialty (2013–2019). by Thomas Hanslmeier (19949694)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  12. 192
    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 193
    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 194
    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 195
    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 196
    Numbers and age-standardized incidence, prevalence, deaths and DALYs rates of peptic ulcer disease in 2021.

    Numbers and age-standardized incidence, prevalence, deaths and DALYs rates of peptic ulcer disease in 2021. by Wende Hao (10315597)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 197
    Numbers and age-standardized incidence, prevalence, deaths and DALYs rates of peptic ulcer disease in 1990.

    Numbers and age-standardized incidence, prevalence, deaths and DALYs rates of peptic ulcer disease in 1990. by Wende Hao (10315597)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 198
    Infection of humanized mice resulted in decrease in pathogenicity in HTLV-1-CTCF infected mice.

    Infection of humanized mice resulted in decrease in pathogenicity in HTLV-1-CTCF infected mice. by Ancy Joseph (5634794)

    Published 2025
    Save to List
    Saved in:
  19. 199
    iKIR score decreases protection associated with protective class II genotypes in T1D.

    iKIR score decreases protection associated with protective class II genotypes in T1D. by Laura Mora-Bitria (20477525)

    Published 2024
    Save to List
    Saved in:
  20. 200
    Prenatal alcohol exposure (PAE) decreases brain and body weights at E14 and P0.

    Prenatal alcohol exposure (PAE) decreases brain and body weights at E14 and P0. by Danielle Sambo (6077924)

    Published 2024
    Save to List
    Saved in:

Search Tools: